日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Autoantibodies as predictors for immune-related adverse events in checkpoint inhibition therapy of metastatic melanoma

自身抗体作为转移性黑色素瘤免疫检查点抑制剂治疗中免疫相关不良事件的预测因子

Reschke, Robin; Budde, Petra; Zucht, Hans-Dieter; Mangana, Johanna; Dummer, Reinhard; Pfoehler, Claudia; Wistuba-Hamprecht, Kilian; Weide, Benjamin; Hakim-Meibodi, Lara-Elena; Meier, Friedegund; Schulz, Carsten; Richter, Jasmin; Bräutigam, Manual; Gutjahr, Claudia; Schulz-Knappe, Peter; Hassel, Jessica C

Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study

III期和IV期黑色素瘤抗PD-1免疫疗法耐药性:一项全球病例回顾研究

Gaughan, Elizabeth M; Kim, Miso; Mendez, Ignacio; Rao, Aparna D; Wei, Maria; So, Alexandra; Zhong, Xiaochen; Berking, Carola; Jiang, Ruixuan; Kim, Tae Min; Dalle, Stéphane; Robert, Caroline; Danson, Sarah; Alam, Salma; Charles, Julie; Davies, Tessa; Debus, Dirk; Dzienis, Marcin; Frazer, Ricky; Gebhardt, Christoffer; Geidel, Glenn; Hassel, Jessica C; Hansen, Inga; Heppt, Markus Vincent; Hildebrandt, Lina; Isaacs, James M; Suh, Koung Jin; Keam, Bhumsuk; Kim, Yu Jung; Lesimple, Thierry; Saiag, Philippe; Delibes, Alicia; Barnett, Rosemarie; Krepler, Clemens; Gandhi, Kavita; Qizilbash, Nawab; Shui, Irene M; Tan, Xiang-Lin; Sullivan, Ryan J

Artificial intelligence-assisted assessment of metabolic response to tebentafusp in metastatic uveal melanoma: a long axial field-of-view [(18)F]FDG PET/CT study

人工智能辅助评估转移性葡萄膜黑色素瘤患者对替苯他福司的代谢反应:一项长轴视野[(18)F]FDG PET/CT研究

Sachpekidis, Christos; Machiraju, Devayani; Strauss, Dimitrios Stefanos; Pan, Leyun; Kopp-Schneider, Annette; Edenbrandt, Lars; Dimitrakopoulou-Strauss, Antonia; Hassel, Jessica C

Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with cutaneous T-cell lymphoma

中等剂量全身照射/氟达拉滨预处理用于皮肤T细胞淋巴瘤患者的异基因造血干细胞移植

Krämer, Isabelle; König, Laila; Brecht, Arne; Hassel, Jessica C; Luft, Thomas; Hegenbart, Ute; Eichkorn, Tanja; Stadtherr, Peter; Müller-Tidow, Carsten; Dreger, Peter

Mycophenolate Mofetil for Treatment of Ipilimumab-Induced Colitis in Patients with Metastatic Melanoma

吗替麦考酚酯治疗转移性黑色素瘤患者伊匹木单抗诱发的结肠炎

Naoum, Christina; Winkler, Julia K; Majenka, Pawel; Loquai, Carmen; Brekner, Annika; Fuchß, Milena; Kähler, Katharina C; Petersen, Marilena; Gutzmer, Ralf; von Wasielewski, Imke; Hassel, Jessica C

COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma

COMBI-EU:达拉非尼联合曲美替尼辅助治疗BRAF V600突变型黑色素瘤患者不良事件管理和治疗时间的真实世界证据

Weichenthal, Michael; Debus, Dirk; Zimmer, Lisa; Wasielewski, Imke von; Meier, Friedegund; Tüting, Thomas; Heppt, Markus V; Hassel, Jessica C; Ziller, Fabian; Mohr, Peter; Dücker, Pia; Sindrilaru, Anca; Dippel, Edgar; Heinzerling, Lucie; Bender, Marc; Aoun, Manar; Walecki, Magdalena; Herbst, Rudolf; Angela, Yenny; Stadler, Rudolf; Haferkampf, Sebastian; Klemke, Claus-Detlev; Kaune, Kjell Matthias; Wohlrab, Johannes; Leiter, Ulrike; Rached, Nessr Abu; Utikal, Jochen; Schley, Gaston; Ulrich, Jens; Schultz, Erwin; Gebhardt, Christoffer; Terheyden, Patrick; Gutzmer, Ralf; Schadendorf, Dirk

Alcian blue-positive stromal phenotype in basal cell carcinoma is associated with progression on first-line hedgehog inhibitors

基底细胞癌中Alcian蓝阳性的基质表型与一线Hedgehog抑制剂治疗后的疾病进展相关。

DeTemple, Viola K; Stadler, Rudolf; Bredemeier, Sabine; Chung, Sungyoung; Schaper-Gerhardt, Katrin; Alter, Mareike; Angela, Yenny; Stege, Henner; Leiter, Ulrike; Ohletz, Jan; Livingstone, Elisabeth; von Wasielewski, Imke; Hassel, Jessica C; Huynh, Julia; Gebhardt, Christoffer; Pföhler, Claudia; Gutzmer, Ralf; Scheel, Christina H

Re-Exposure of a PD-1 Inhibitor After Previous Immune-Related Adverse Events

既往发生免疫相关不良事件后再次使用PD-1抑制剂

Burghaus-Zhang, Jana; Schulz, Carsten; Ramelyte, Egle; Mangana, Joanna; Özistanbullu, Deniz; Kleemann, Johannes; Enk, Alexander; Hassel, Jessica C

Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma

LOGIC 2 研究的简明语言摘要:恩考拉非尼、比美替尼联合第三种药物治疗 BRAF V600 突变型黑色素瘤患者

Dummer, Reinhard; Sandhu, Shahneen; Miller, Wilson H Jr; Butler, Marcus O; Taylor, Matthew H; Heinzerling, Lucie; Blank, Christian U; Couselo, Eva Muñoz; Burris, Howard A 3rd; Postow, Michael A; Chmielowski, Bartosz; Middleton, Mark R; Berking, Carola; Hassel, Jessica C; Gesierich, Anja Heike; Mauch, Cornelia; Kleha, Joseph F; Polli, Anna; Harney, Allison S; di Pietro, Alessandra; Ascierto, Paolo A

Tebentafusp, a T cell engager, promotes macrophage reprogramming and in combination with IL-2 overcomes macrophage immunosuppression in cancer

Tebentafusp 是一种 T 细胞衔接剂,可促进巨噬细胞重编程,并与 IL-2 联合使用可克服癌症中的巨噬细胞免疫抑制。

Güç, Esra; Treveil, Agatha; Leach, Emma; Broomfield, Anna; Camera, Antonio; Clubley, James; Nieto Garcia, Paula; Kazachenka, Anastasiya; Khanolkar, Rahul; Del Carpio, Luis; Heyn, Holger; Hassel, Jessica C; Sacco, Joseph J; Stanhope, Sarah; Collins, Laura; Piulats, Josep M; Ranade, Koustubh; Benlahrech, Adel